Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1978 1
1987 1
1988 2
1989 3
1990 3
1991 4
1992 3
1993 2
1994 13
1995 21
1996 21
1997 30
1998 17
1999 12
2000 18
2001 19
2002 10
2003 14
2004 16
2005 21
2006 25
2007 19
2008 11
2009 16
2010 14
2011 13
2012 18
2013 13
2014 11
2015 15
2016 10
2017 14
2018 16
2019 9
2020 9
2021 9
2022 11
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

452 results

Results by year

Filters applied: . Clear all
Page 1
Multiple endocrine neoplasia type 2: A review.
Mathiesen JS, Effraimidis G, Rossing M, Rasmussen ÅK, Hoejberg L, Bastholt L, Godballe C, Oturai P, Feldt-Rasmussen U. Mathiesen JS, et al. Semin Cancer Biol. 2022 Feb;79:163-179. doi: 10.1016/j.semcancer.2021.03.035. Epub 2021 Apr 1. Semin Cancer Biol. 2022. PMID: 33812987 Review.
Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant potential. Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary cancer syndrome due to germline variants in the REarranged …
Multiple endocrine neoplasias are rare hereditary syndromes some of them with malignant potential. Multiple endocrin …
Somatostatin receptors: from signaling to clinical practice.
Theodoropoulou M, Stalla GK. Theodoropoulou M, et al. Front Neuroendocrinol. 2013 Aug;34(3):228-52. doi: 10.1016/j.yfrne.2013.07.005. Epub 2013 Jul 18. Front Neuroendocrinol. 2013. PMID: 23872332 Review.
Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Somatostatin receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G protein …
Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological man …
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Wells SA Jr, et al. Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. Thyroid. 2015. PMID: 25810047 Free PMC article. Review.
Management of medullary carcinoma of the thyroid: a review.
Jayasinghe R, Basnayake O, Jayarajah U, Seneviratne S. Jayasinghe R, et al. J Int Med Res. 2022 Jul;50(7):3000605221110698. doi: 10.1177/03000605221110698. J Int Med Res. 2022. PMID: 35822284 Free PMC article. Review.
Although infrequent, the interest in this cancer exceeds its incidence owing to its distinctive features and its characteristic association with other endocrine tumors. Although the majority of MTCs are sporadic, hereditary varieties occur in isolation or as a part of m …
Although infrequent, the interest in this cancer exceeds its incidence owing to its distinctive features and its characteristic association …
Therapeutic implications of menin inhibition in acute leukemias.
Issa GC, Ravandi F, DiNardo CD, Jabbour E, Kantarjian HM, Andreeff M. Issa GC, et al. Leukemia. 2021 Sep;35(9):2482-2495. doi: 10.1038/s41375-021-01309-y. Epub 2021 Jun 15. Leukemia. 2021. PMID: 34131281 Review.
Menin inhibitors are novel targeted agents currently in clinical development for the treatment of genetically defined subsets of acute leukemia. Menin has a tumor suppressor function in endocrine glands. Germline mutations in the gene encoding menin cause the multiple …
Menin inhibitors are novel targeted agents currently in clinical development for the treatment of genetically defined subsets of acute leuke …
Update on multiple endocrine neoplasia Type 1 and 2.
Al-Salameh A, Baudry C, Cohen R. Al-Salameh A, et al. Presse Med. 2018 Sep;47(9):722-731. doi: 10.1016/j.lpm.2018.03.005. Epub 2018 Jun 13. Presse Med. 2018. PMID: 29909163 Review.
Multiple endocrine neoplasia type 1 is a rare genetic syndrome, characterized by the co-occurrence, in the same individual or in related individuals of the same family, of hyperparathyroidism, duodenopancraetic neuroendocrine tumors, pituitary adenomas …
Multiple endocrine neoplasia type 1 is a rare genetic syndrome, characterized by the co-occurrence, in the same …
Structure and function of RET in multiple endocrine neoplasia type 2.
Plaza-Menacho I. Plaza-Menacho I. Endocr Relat Cancer. 2018 Feb;25(2):T79-T90. doi: 10.1530/ERC-17-0354. Epub 2017 Nov 24. Endocr Relat Cancer. 2018. PMID: 29175871 Review.
It has been twenty-five years since the discovery of oncogenic germline RET mutations as the cause of multiple endocrine neoplasia type 2 (MEN2). Intensive work over the last two and a half decades on RET genetics, signaling and cell biology has provid …
It has been twenty-five years since the discovery of oncogenic germline RET mutations as the cause of multiple endocrine ne …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Multiple endocrine neoplasia, the old and the new: a mini review.
Pasquali D, Di Matteo FM, Renzullo A, Accardo G, Esposito D, Barbato F, Colantuoni V, Circelli L, Conzo G. Pasquali D, et al. G Chir. 2012 Nov-Dec;33(11-12):370-3. G Chir. 2012. PMID: 23140918 Review.
Multiple endocrine neoplasia syndromes have since been classified as types 1 and 2, each with specific phenotypic patterns. ...Recently, Pellegata et al. have reported that germline mutations in CDKN1B can predispose to the development of multiple e …
Multiple endocrine neoplasia syndromes have since been classified as types 1 and 2, each with specific phenotypic patte …
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Wells SA Jr, Pacini F, Robinson BG, Santoro M. Wells SA Jr, et al. J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6. J Clin Endocrinol Metab. 2013. PMID: 23744408 Free PMC article. Review.
CONTEXT: Over the last decade, our knowledge of the multiple endocrine neoplasia (MEN) type 2 syndromes MEN2A and MEN2B and familial medullary thyroid carcinoma (FMTC) has expanded greatly. ...EVIDENCE ACQUISITION: We reviewed the English literature th …
CONTEXT: Over the last decade, our knowledge of the multiple endocrine neoplasia (MEN) type 2 syndromes MEN2A an …
452 results